Company Profile
Champions Oncology Stock Price, News & Analysis
- Ticker:
- CSBR
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
5.81 USD (-0.17%)
Close
Last updated: July 13, 2026 at 00:00
80.82M USD
Market cap
Why the stock is moving
CSBR is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Champions Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Champions Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Business Model Characteristics
Champions Oncology follows a pipeline-and-commercial model where investors track trial execution, launch cadence, and the pace at which oncology data can be turned into durable product value.
Position Within the Biotechnology Landscape
Compared with larger diversified peers, Champions Oncology sits in a high-catalyst corner of the biotech landscape, where oncology updates can reprice the stock quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Champions Oncology (CSBR)?
Champions Oncology (CSBR) most recently closed at 5.81 USD, a -0.17% move versus the previous session.
What is the market cap of Champions Oncology (CSBR)?
Champions Oncology currently has a market capitalization of 80.82M USD on BioPharmSignal.
What does Champions Oncology do?
Champions Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
On which exchange is CSBR stock listed?
Champions Oncology (CSBR) is associated with NASDAQ, United States, Biotechnology.
What is Champions?
Champions Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Which conditions is Champions Oncology targeting with Champions?
Champions Oncology is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
What is Oncology?
Champions Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.